CRISPR/Cas System: An Effective Tool Against Pathogenic Diseases

Aslam, Shakira; Umair, Ali; Aslam, Zaid; Saleem, Muhammad Zafar; Bashir, Hamid

doi:10.2478/am-2023-0009

Abstract

Viral pathogens are major concern nowadays. Bacterial CRISPR/Cas systems help in defending the host body against different pathogens including viruses too. This system contains restriction enzymes that introduce dsDNA breaks on target site to make the virus non-functional by damaging its genes. Coronavirus, HIV and Herpes viruses are causing mortality all around the world. To control the spread of disease, early detection and treatment is required. CRISPR system due to its high efficiency provides a platform to restrict the viral entry into host cell, viral genome editing and eliminate the latent infections. In this review, the CRISPR strategies against three major viral diseases are put under consideration: Coronavirus, Acquired Immunodeficiency Syndrome and Herpesvirus associated diseases. Three CRISPR/Cas systems have been discussed including CRISPR/Cas12, CRISPR/Cas9 and CRISPR/Cas13 that are used against the above listed viruses.

References

Abbott T.R. & Dhamdhere G. et al.: Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza. Cell, 181, 865–876 (2020)
Search in Google Scholar Back to article
Afkhami S., Yao Y., Xing Z.: Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens. Mol. Ther. Methods Clin. Dev. 3, 16030 (2016)
Search in Google Scholar Back to article
Amitai G., Sorek R.: CRISPR-Cas adaptation: insights into the mechanism of action. Nat. Rev. Microbiol. 14, 67 (2016)
Search in Google Scholar Back to article
Artika I.M., Wiyatno A., Ma’roef C.N.: Pathogenic viruses: Molecular detection and characterization. Infect. Genet. Evol. 81, 104215 (2020)
Search in Google Scholar Back to article
Barrangou R., Doudna J.A.: Applications of CRISPR technologies in research and beyond. Nat. Biotechnol. 34, 933–941 (2016)
Search in Google Scholar Back to article
Bella R. & Kaminski R. et al.: Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice. Mol. Ther Nucleic Acids, 12, 275–282 (2018)
Search in Google Scholar Back to article
Bikard D., Hatoum-Aslan A., Mucida D., Marraffini L.A.: CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection. Cell Host Microbe, 12, 177–186 (2012)
Search in Google Scholar Back to article
Biti R., Ffrench R., Young J., Bennetts B., Stewart G., Liang T.: HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nature med. 3, 252–253 (1997)
Search in Google Scholar Back to article
Bowers N.L., Helton E.S., Huijbregts R.P., Goepfert P.A.., Heath S.L., Hel Z.: Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway. PLoS Pathog. 10, e1003993 (2014)
Search in Google Scholar Back to article
Broughton J.P., Deng X., Yu G., Fasching C.L., Servellita V., Singh J., Miao X., Streithorst J.A., Granados A., Sotomayor-Gonzalez A.: CRISPR-Cas12-based detection of SARS-CoV-2. Nat. Biotechnol. 38, 870–874 (2020)
Search in Google Scholar Back to article
Brouns S.J., Jore M.M., Lundgren M., Westra E.R., Slijkhuis R.J., Snijders A.P., Dickman M.J., Makarova K.S., Koonin E.V.: Small CRISPR RNAs guide antiviral defense in prokaryotes. Science, 321, 960–964 (2008)
Search in Google Scholar Back to article
Cassan E., Arigon-Chifolleau A.M., Mesnard J.M., Gross A., Gascuel O.: Concomitant emergence of the antisense protein gene of HIV-1 and of the pandemic. Proc. Natl. Acad. Sci. 113, 11537–11542 (2016)
Search in Google Scholar Back to article
Ceasar S.A., Rajan V., Prykhozhij S.V., Berman J.N., Ignacimuthu S.: Insert, remove or replace: A highly advanced genome editing system using CRISPR/Cas9. Biochem. Biophys. Acta, 1863, 2333–2344 (2016)
Search in Google Scholar Back to article
Center C.R.: Center for Systems Science and Engineering, Johns Hopkins Coronavirus Resource Center. COVID-19 Dashboard, https://coronavirus.jhu.edu/map.html (2022)
Search in Google Scholar Back to article
Charpentier E., Marraffini L.A.: Harnessing CRISPR-Cas9 immunity for genetic engineering. Curr. Opin. Microbiol. 19, 114–119 (2014)
Search in Google Scholar Back to article
Chaudhuri A., Halder K., Datta A.: Classification of CRISPR/Cas system and its application in tomato breeding. Theor. Appl. Genet. 135, 367–387 (2022)
Search in Google Scholar Back to article
Chavez L., Calvanese V., Verdin E.: HIV latency is established directly and early in both resting and activated primary CD4 T cells. PLoS Pathog. 11, e1004955 (2015)
Search in Google Scholar Back to article
Chen S., Yu X., Guo D.: CRISPR-Cas targeting of host genes as an antiviral strategy. Viruses, 10, 40 (2018)
Search in Google Scholar Back to article
Chen X., Rinsma M., Janssen J.M., Liu J., Maggio I., Gonçalves M.A.: Probing the impact of chromatin conformation on genome editing tools. Nucleic Acids Res. 44, 6482–6492 (2016)
Search in Google Scholar Back to article
Cho S.W., Kim S., Kim J.M., Kim J.S.: Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat. Biotechnol. 31, 230–232 (2013)
Search in Google Scholar Back to article
Chun T.W., Nickle D.C., Justement J.S., Meyers J.H., Roby G., Hallahan C.W., Kottilil S., Moir S., Mican J.M., Mullins J.I.: Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J. Infect. Dis. 197, 714–720 (2008)
Search in Google Scholar Back to article
Coen D.M., Schaffer P.A.: Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets. Nat. Rev. Drug Discov. 2, 278–288 (2003)
Search in Google Scholar Back to article
Cohen M.S., Shaw G.M., McMichael A.J., Haynes B.F.: Acute HIV-1 infection. N. Engl. J. Med. 364, 1943–1954 (2011)
Search in Google Scholar Back to article
Cui J., Li F., Shi Z.L.: Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 17, 181–192 (2019)
Search in Google Scholar Back to article
De Wit E., Van Doremalen N., Falzarano D., Munster V.J.: SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 14, 523 (2016)
Search in Google Scholar Back to article
Deltcheva E., Chylinski K., Sharma C.M., Gonzales K., Chao Y., Pirzada Z.A., Eckert M.R., Vogel J., Charpentier E.: CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature, 471, 602–607 (2011)
Search in Google Scholar Back to article
Diner B.A., Lum K.K., Toettcher J.E., Cristea I.M.: Viral DNA sensors IFI16 and cyclic GMP-AMP synthase possess distinct functions in regulating viral gene expression, immune defenses, and apoptotic responses during herpesvirus infection. MBio, 7, e01553 (2016)
Search in Google Scholar Back to article
Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R.: A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87, 1–9 (2000)
Search in Google Scholar Back to article
Doudna J.A., Charpentier E.: The new frontier of genome engineering with CRISPR-Cas9. Science, 346, 6213 (2014)
Search in Google Scholar Back to article
Duan J., Lu G., Xie Z., Lou M., Luo J., Guo L., Zhang Y.: Genome-wide identification of CRISPR/Cas9 off-targets in human genome. Cell res. 24, 1009–1012 (2014)
Search in Google Scholar Back to article
Ebina H., Misawa N., Kanemura Y., Koyanagi Y.: Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci. Rep. 3, 1–7 (2013)
Search in Google Scholar Back to article
Ebrahimi S., Khanbabaei H., Abbasi S., Fani M., Soltani S., Zandi M., Najafimemar Z.: CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19. Avicenna J. Med. Biotechnol. 14, 3–9 (2022)
Search in Google Scholar Back to article
Eggleton J.S., Nagalli S.: Highly active antiretroviral therapy (HAART). StatPearls, 4 (2020)
Search in Google Scholar Back to article
Fätkenheuer G., Nelson M., Lazzarin A., Konourina I., Hoepelman A.I., Lampiris H., Hirschel B., Tebas P., Raffi F., Trottier B.: Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection. N. Engl. J. Med. 359, 1442–1455 (2008)
Search in Google Scholar Back to article
Fehr A.R., Perlman S.: Coronaviruses: an overview of their replication and pathogenesis. Methods Mol. Biol. 1282, 1–23 (2015)
Search in Google Scholar Back to article
Fischer-Smith T., Croul S., Sverstiuk A.E., Capini C., L’Heureux D., Régulier E.G., Richardson M.W., Amini S., Morgello S., Khalili K.: CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J. NeuroVirology, 7, 528–541 (2001)
Search in Google Scholar Back to article
Gallastegui E., Millán-Zambrano G., Terme J.M., Chávez S., Jordan A.: Chromatin reassembly factors are involved in transcriptional interference promoting HIV latency. J. Virol. 85, 3187–3202 (2011)
Search in Google Scholar Back to article
Garneau J.E., Dupuis M.-È., Villion M., Romero D.A., Barrangou R., Boyaval P., Fremaux C., Horvath P., Magadán A.H., Moineau S.: The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature, 468, 67–71 (2010)
Search in Google Scholar Back to article
Gasiunas G., Barrangou R., Horvath P., Siksnys V.: Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. 109, e2579 (2012)
Search in Google Scholar Back to article
Gootenberg J.S., Abudayyeh O.O., Kellner M.J., Joung J., Collins J.J., Zhang F.: Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science, 360, 439–444 (2018)
Search in Google Scholar Back to article
Gootenberg J.S., Abudayyeh O.O., Lee J.W., Essletzbichler P., Dy A.J., Joung J., Verdine V., Donghia N., Daringer N.M., Freije C.A.: Nucleic acid detection with CRISPR-Cas13a/C2c2. Science, 356, 438–442 (2017)
Search in Google Scholar Back to article
Gorbalenya A.E. & Baker S.C. et al.: The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5, 536 (2020)
Search in Google Scholar Back to article
Griffin B.D., Verweij M.C., Wiertz E.J.: Herpesviruses and immunity: the art of evasion. Vet. Microbiol. 143, 89–100 (2010)
Search in Google Scholar Back to article
Guy J.L., Jackson R.M., Jensen H.A., Hooper N.M., Turner A.J.: Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis. FEBS Lett. 272, 3512 (2005)
Search in Google Scholar Back to article
Heidenreich M., Zhang F.: Applications of CRISPR-Cas systems in neuroscience. Nat. Rev. Neurosci. 17, 36 (2016)
Search in Google Scholar Back to article
Hladik F., McElrath M.J.: Setting the stage: host invasion by HIVNat. Rev. Immunol. 8, 447–457 (2008)
Search in Google Scholar Back to article
Horlbeck M.A., Witkowsky L.B., Guglielmi B., Replogle J.M., Gilbert L.A., Villalta J.E., Torigoe S.E., Tjian R., Weissman J.S.: Nucleosomes impede Cas9 access to DNA in vivo and in vitro. Elife, 5, e12677 (2016)
Search in Google Scholar Back to article
Hou P., Chen S., Wang S., Yu X., Chen Y., Jiang M., Zhuang K., Ho W., Hou W., Huang J.: Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection. Sci. Rep. 5, 1–12 (2015)
Search in Google Scholar Back to article
Hsu P.D., Lander E.S., Zhang F.: Development and applications of CRISPR-Cas9 for genome engineering. Cell, 157, 1262–1278 (2014)
Search in Google Scholar Back to article
Hu W., Kaminski R., Yang F., Zhang Y., Cosentino L., Li F., Luo B., Alvarez-Carbonell D., Garcia-Mesa Y., Karn J.: RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. Proc. Natl. Acad. Sci. 111, 11461–11466 (2014)
Search in Google Scholar Back to article
Huang S.H. & Ren Y. et al.: Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells. J. Clin. Invest. 128, 876–889 (2018)
Search in Google Scholar Back to article
Hultquist J.F., Schumann K., Woo J.M., Manganaro L., McGregor M.J., Doudna J., Simon V., Krogan N.J., Marson A.: A Cas9 ribonucleoprotein platform for functional genetic studies of HIV-host interactions in primary human T cells. Cell rep. 17, 1438–1452 (2016)
Search in Google Scholar Back to article
Jiang F., Doudna J.A.: CRISPR/Cas9 structures and mechanisms. Annu. Rev. Biophys. 46, 505–529 (2017)
Search in Google Scholar Back to article
Jiang W., Bikard D., Cox D., Zhang F., Marraffini L.A.: RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 31, 233–239 (2013)
Search in Google Scholar Back to article
Jinek M., Chylinski K., Fonfara I., Hauer M., Doudna J.A., Charpentier E.: A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity. Science, 337, 816–821 (2012)
Search in Google Scholar Back to article
Johnson K.E., Bottero V., Flaherty S., Dutta S., Singh V.V., Chandran B.: IFI16 restricts HSV-1 replication by accumulating on the hsv-1 genome, repressing HSV-1 gene expression, and directly or indirectly modulating histone modifications. PLoS Pathog, 10, e1004503 (2014)
Search in Google Scholar Back to article
Joyce M.G., Sankhala R.S., Chen W.H., Choe M., Bai, H., Hajduczki A., Yan L., Sterling S.L., Peterson C.E., Green E.C.: A cryptic site of vulnerability on the receptor binding domain of the SARS-CoV-2 spike glycoprotein. bioRxiv. 3, 15 (2020)
Search in Google Scholar Back to article
Kaminski R., Chen Y., Salkind J., Bella R., Young W.B., Ferrante P., Karn J., Malcolm T., Hu W., Khalili K.: Negative feedback regulation of HIV-1 by gene editing strategy. Sci. Rep. 6, 1–11 (2016)
Search in Google Scholar Back to article
Kim S., Koo T., Jee H.G., Cho H.Y., Lee G., Lim D.G., Shin H.S., Kim J.S.: CRISPR RNAs trigger innate immune responses in human cells. Genome Res. 28, 367–373 (2018)
Search in Google Scholar Back to article
Kimberland M.L., Hou W., Alfonso-Pecchio A., Wilson S., Rao Y., Zhang S., Lu Q.: Strategies for controlling CRISPR/ Cas9 off-target effects and biological variations in mammalian genome editing experiments. J. Biotechnol. 284, 91–101 (2018)
Search in Google Scholar Back to article
Konermann S., Lotfy P., Brideau N.J., Oki J., Shokhirev M.N., Hsu P.D.: Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors. Cell, 173, 665–676 (2018)
Search in Google Scholar Back to article
Kuba K., Imai Y., Ohto-Nakanishi T., Penninger J.M.: Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol. Ther. 128, 119–128 (2010)
Search in Google Scholar Back to article
Lebbink R.J., De Jong D.C., Wolters F., Kruse E.M., Van Ham P.M., Wiertz E.J., Nijhuis M.: A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape. Sci. Rep. 7, 1–10 (2017)
Search in Google Scholar Back to article
Lenasi T., Contreras X., Peterlin B.M.: Transcriptional interference antagonizes proviral gene expression to promote HIV latency. Cell host microbe, 4, 123–133 (2008)
Search in Google Scholar Back to article
Li C., Guan X., Du T., Jin W., Wu B., Liu Y., Wang P., Hu B., Griffin G.E., Shattock R.J.: Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9. J. Gen. Virol. 96, 2381–2393 (2015)
Search in Google Scholar Back to article
Liang C., Wainberg M.A., Das A.T., Berkhout B.: CRISPR/Cas9: a double-edged sword when used to combat HIV infection. Retrovirology, 13, 1–4 (2016)
Search in Google Scholar Back to article
Liao H.K., Gu Y., Diaz A., Marlett J., Takahashi Y., Li M., Suzuki K., Xu R., Hishida T., Chang C.J.: Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells. Nat. Commun. 6, 1–10 (2015)
Search in Google Scholar Back to article
Liu J., Zheng X., Tong Q., Li W., Wang B., Sutter K., Trilling M., Lu M., Dittmer U., Yang D.: Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J. Med. Virol. 92, 491–494 (2020)
Search in Google Scholar Back to article
Liu M., Rehman S., Tang X., Gu K., Fan Q., Chen D., Ma W.: Methodologies for improving HDR efficiency. Front. Genet. 9, 691 (2019)
Search in Google Scholar Back to article
Liu Z., Torresilla C., Xiao Y., Nguyen P.T., Caté C., Barbosa K., Rassart É., Cen S., Bourgault S., Barbeau B.: HIV-1 antisense protein of different clades induces autophagy and associates with the autophagy factor p62. J. Virol. 93, e01757 (2019)
Search in Google Scholar Back to article
Maeder M.L., Gersbach C.A.: Genome-editing technologies for gene and cell therapy. Mol. Ther. 24, 430–446 (2016)
Search in Google Scholar Back to article
Makarova K.S., Aravind L., Wolf Y.I., Koonin E.V.: Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems. Biol. Direct, 6, 1–27 (2011)
Search in Google Scholar Back to article
Marraffini L.A., Sontheimer E.J.: Self versus non-self discrimination during CRISPR RNA-directed immunity. Nature, 463, 568–571 (2010)
Search in Google Scholar Back to article
Mei Y., Wang Y., Chen H., Sun Z.S., Ju X.D.: Recent progress in CRISPR/Cas9 technology. J. Genet. Genomics, 43, 63–75 (2016)
Search in Google Scholar Back to article
Ming S., Tian-Rui X., Ce-Shi C.: The big bang of genome editing technology: development and application of the CRISPR/Cas9 system in disease animal models. Zool. Res. 37, 191 (2016)
Search in Google Scholar Back to article
Mocarski E., Shenk T., Griffiths P.D., Pass R.: Cytomegaloviruses. Fields Virology: Sixth Edition, 1, 1960–2014 (2013)
Search in Google Scholar Back to article
Nalawansha D.A., Samarasinghe K.T.: Double-barreled CRISPR technology as a novel treatment strategy for COVID-19. ACS Pharmacol. Transl. Sci. 3, 790–800 (2020)
Search in Google Scholar Back to article
Narasipura S.D., Kim S., Al-Harthi L.: Epigenetic regulation of HIV-1 latency in astrocytes. J. Virol. 88, 3031–3038 (2014)
Search in Google Scholar Back to article
Nath A.: Eradication of human immunodeficiency virus from brain reservoirs. J. NeuroVirology, 21, 227–234 (2015)
Search in Google Scholar Back to article
Nguyen T.M., Zhang Y., Pandolfi P.P.: Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses. Cell Res. 30, 189–190 (2020)
Search in Google Scholar Back to article
Nicoll M.P., Proença J.T., Efstathiou S.: The molecular basis of herpes simplex virus latency. FEMS Microbiol. Rev. 36, 684–705 (2012)
Search in Google Scholar Back to article
Nyamweya S., Hegedus A., Jaye A., Rowland-Jones S., Flanagan K.L., Macallan D.C.: Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis. Rev. Med. Virol. 23, 221–240 (2013)
Search in Google Scholar Back to article
Panno S., Matić S., Tiberini A., Caruso A.G., Bella P., Torta L., Stassi R., Davino S.: Loop mediated isothermal amplification: principles and applications in plant virology. Plants, 9, 461 (2020)
Search in Google Scholar Back to article
Park R.J., Wang T., Koundakjian D., Hultquist J.F., Lamothe-Molina P., Monel B., Schumann K., Yu H., Krupzcak K.M., Garcia-Beltran W.: A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors. Nat. Genet. 49, 193–203 (2017)
Search in Google Scholar Back to article
Pearson T., Shultz L.D., Miller D., King M., Laning J., Fodor W., Cuthbert A., Burzenski L., Gott B., Lyons B.: Non-obese diabetic-recombination activating gene-1 (NOD-Rag 1 null) interleukin (IL)-2 receptor common gamma chain (IL 2 rγ null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Clin. Exp. Immunol. 154, 270–284 (2008)
Search in Google Scholar Back to article
Pellet P.E., Roizmann B.: Herpesviridae. Fields virology, 1, 1802–1822 (2013)
Search in Google Scholar Back to article
Perlman S., Netland J.: Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 7, 439–450 (2009)
Search in Google Scholar Back to article
Rappuoli R.: Glycoconjugate vaccines: Principles and mechanisms Sci. Transl. Med. 10, 456 (2018)
Search in Google Scholar Back to article
Rauch J.N. & Valois E. et al.: A scalable, easy-to-deploy protocol for Cas13-based detection of SARS-CoV-2 genetic material. J. Clin. Microbiol. 59, 4 (2021)
Search in Google Scholar Back to article
Rice G.I., Thomas D.A., Grant P.J., Turner A.J., Hooper N.M.: Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem. J. 383, 45–51 (2004)
Search in Google Scholar Back to article
Roehm P., Shekarabi M., Wollebo H., Bellizzi A., He L., Salkind J., Khalili K.: Inhibition of HSV-1 replication by gene editing strategy. Sci. Rep. 6, 23146 (2016)
Search in Google Scholar Back to article
Roizmann B., Knipe D.M., Whitley R.: Herpes simplex viruses. Fields virology, 1, 1823–1897 (2013)
Search in Google Scholar Back to article
Ruelas D.S., Chan J.K., Oh E., Heidersbach A.J., Hebbeler A.M., Chavez L., Verdin E., Rape M., Greene W.C.: MicroRNA-155 reinforces HIV latency. J. Biol. Chem. 290, 13736–13748 (2015)
Search in Google Scholar Back to article
Russell T.A., Stefanovic T., Tscharke D.C.: Engineering herpes simplex viruses by infection–transfection methods including recombination site targeting by CRISPR/Cas9 nucleases. J. Virol. Methods. 213, 18–25 (2015)
Search in Google Scholar Back to article
Safari F., Afarid M., Rastegari B., Haghighi A.B., Barekati-Mowahed M., Behbahani A.B.: CRISPR systems: Novel approaches for detection and combating COVID-19. Virus Res. 294, 198282 (2021)
Search in Google Scholar Back to article
Siddell S.G., Walker P.J., Lefkowitz E.J., Mushegian A.R., Adams M.J., Dutilh B.E., Gorbalenya A.E., Harrach B., Harrison R.L., Junglen S.: Additional changes to taxonomy ratified in a special vote by the International Committee on Taxonomy of Viruses. Arch. Virol. 164, 943–946 (2019)
Search in Google Scholar Back to article
Siliciano J.D., Kajdas J., Finzi D., Quinn T.C., Chadwick K., Margolick J.B., Kovacs C., Gange S.J., Siliciano R.F.: Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nature med. 9, 727–728 (2003)
Search in Google Scholar Back to article
Simmons G., Reeves J.D., Rennekamp A.J., Amberg S.M., Piefer A.J., Bates P.: Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. 101, 4240–4245 (2004)
Search in Google Scholar Back to article
Smith P.D., Meng G., Salazar-Gonzalez J.F., Shaw G.M.: Macrophage HIV-1 infection and the gastrointestinal tract reservoir. J. Leukoc. Biol. 74, 642–649 (2003)
Search in Google Scholar Back to article
Song Z., Xu Y., Bao L., Zhang L., Yu P., Qu Y., Zhu H., Zhao W., Han Y., Qin C.: From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses, 11, 59 (2019)
Search in Google Scholar Back to article
Stern-Ginossar N., Weisburd B., Michalski A., Le V.T.K., Hein M.Y., Huang S.X., Ma M., Shen B., Qian S.B., Hengel H.: Decoding human cytomegalovirus. Science, 338, 1088–1093 (2012)
Search in Google Scholar Back to article
Strong A., Musunuru K.: Genome editing in cardiovascular diseases. Nature Rev. Cardiol. 14, 11 (2017)
Search in Google Scholar Back to article
Su S., Wong G., Shi W., Liu J., Lai A.C., Zhou J., Liu W., Bi Y., Gao G.F.: Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends microbiol. 24, 490–502 (2016)
Search in Google Scholar Back to article
Sunshine S. & Kirchner R. et al.: HIV integration site analysis of cellular models of HIV latency with a probe-enriched next-generation sequencing assay. J. Virol. 90, 4511–4519 (2016)
Search in Google Scholar Back to article
Tanaka P. & Santos J. et al.: A Crispr-Cas9 system designed to introduce point mutations into the human ACE2 gene to weaken the interaction of the ACE2 receptor with the SARS-CoV-2 S protein. Preprints.org. 1, 2020050134 (2020)
Search in Google Scholar Back to article
van Boheemen S. & de Graaf M. et al.: Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio, 3, e00473 (2012)
Search in Google Scholar Back to article
Van Der Oost J., Westra E.R., Jackson R.N., Wiedenheft B.: Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat. Rev. Microbiol. 12, 479–492 (2014)
Search in Google Scholar Back to article
van Diemen F.R., Kruse E.M., Hooykaas M.J., Bruggeling C.E., Schürch A.C., van Ham P.M., Imhof S.M., Nijhuis M., Wiertz E.J., Lebbink R.J.: CRISPR/Cas9-mediated genome editing of herpesviruses limits productive and latent infections. PLoS pathog. 12, e1005701 (2016)
Search in Google Scholar Back to article
van Diemen F.R., Lebbink R.J.: CRISPR/Cas9, a powerful tool to target human herpesviruses. Cell. Microbiol. 19, e12694 (2017)
Search in Google Scholar Back to article
Verheyen J. & Thielen A. et al.: Rapid rebound of a preexisting CXCR4-tropic human immunodeficiency virus variant after allogeneic transplantation with CCR5 Δ32 homozygous stem cells. Clin. Infect. Dis. 68, 684–687 (2019)
Search in Google Scholar Back to article
von Eije K.J., Ter Brake O., Berkhout B.: Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J. Virol. 82, 2895–2903 (2008)
Search in Google Scholar Back to article
Wang D., Zhang F., Gao G.: CRISPR-based therapeutic genome editing: strategies and in vivo delivery by AAV vectors. Cell, 181, 136–150 (2020)
Search in Google Scholar Back to article
Wang G., Zhao N., Berkhout B., Das A.T.: CRISPR-Cas9 can inhibit HIV-1 replication but NHEJ repair facilitates virus escape. Mol. Ther. 24, 522–526 (2016)
Search in Google Scholar Back to article
Wang H., La Russa M., Qi L.S.: CRISPR/Cas9 in genome editing and beyond. Annu. Rev. Biochem. 85, 227–264 (2016)
Search in Google Scholar Back to article
Wang H., Yang P., Liu K., Guo F., Zhang Y., Zhang G., Jiang C.: SARS coronavirus entry into host cells through a novel clathrin-and caveolae-independent endocytic pathway. Cell res. 18, 290–301 (2008)
Search in Google Scholar Back to article
Wang J., Quake S.R.: RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection. Proc. Natl. Acad. Sci. 111: 13157–13162 (2014)
Search in Google Scholar Back to article
Wright A.V., Nuñez J.K., Doudna J.A.: Biology and applications of CRISPR systems: harnessing nature’s toolbox for genome engineering. Cell, 164, 29–44 (2016)
Search in Google Scholar Back to article
Wu A. & Peng Y. et al.: Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell host microbe, 27: 325–328 (2020)
Search in Google Scholar Back to article
Wu F. & Zhao S. et al.: A new coronavirus associated with human respiratory disease in China. Nature, 579, 265–269 (2020)
Search in Google Scholar Back to article
Xiang X., Qian K., Zhang Z., Lin F., Xie Y., Liu Y., Yang Z.: CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia. J. Drug Target. 28, 727–731 (2020)
Search in Google Scholar Back to article
Xiong X., Chen M., Lim W.A., Zhao D., Qi L.S.: CRISPR/Cas9 for human genome engineering and disease research. Annu. Rev. Genomics Hum. Genet. 17, 131–154 (2016)
Search in Google Scholar Back to article
Xu X., Fan S., Zhou J., Zhang, Y., Che Y., Cai, H., Wang L., Guo L., Liu L., Li Q.: The mutated tegument protein UL7 attenuates the virulence of herpes simplex virus 1 by reducing the modulation of α-4 gene transcription. Virol. J. 13, 1–12 (2016)
Search in Google Scholar Back to article
Yan W.X., Chong S., Zhang H., Makarova K.S., Koonin E.V., Cheng D.R., Scott D.A.: Cas13d is a compact RNA-targeting type VI CRISPR effector positively modulated by a WYL-domain-containing accessory protein. Mol. Cell, 70, 327–339 (2018)
Search in Google Scholar Back to article
Yang H., Gao P., Rajashankar K.R., Patel D.J.: PAM-dependent target DNA recognition and cleavage by C2c1 CRISPR-Cas endonuclease. Cell, 167, 1814–1828 (2016)
Search in Google Scholar Back to article
Yang H., Ren S., Yu S., Pan H., Li T., Ge S., Zhang J., Xia N.: Methods favoring homology-directed repair choice in response to CRISPR/Cas9 induced-double strand breaks. Int. J. Mol. Sci. 21, 6461 (2020)
Search in Google Scholar Back to article
Yuan M., Wu N.C., Zhu X., Lee C.C.D., So R.T., Lv H., Mok C.K., Wilson I.A.: A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science, 368, 630–633 (2020)
Search in Google Scholar Back to article
Yuen K.S., Wang Z.M., Wong N.H.M., Zhang Z.Q., Cheng T.F., Lui W.Y., Chan C.P., Jin D.Y.: Suppression of Epstein-Barr virus DNA load in latently infected nasopharyngeal carcinoma cells by CRISPR/Cas9. Virus res. 244, 296–303 (2018)
Search in Google Scholar Back to article
Zetsche B., Gootenberg J.S., Abudayyeh O.O., Slaymaker I.M., Makarova K.S., Essletzbichler P., Volz S.E., Joung J., Van Der Oost J., Regev A.: Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell, 163, 759–771 (2015)
Search in Google Scholar Back to article
Zhang F., Abudayyeh O.O., Gootenberg J.S.: A protocol for detection of COVID-19 using CRISPR diagnostics. Howard Hughes Medical Institute, 1, 1–8 (2020)
Search in Google Scholar Back to article
Zhou P. & Yang X.L. et al.: Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. BioRxiv, doi: 10.1101/2020.01.22.914952 (2020)
Open DOI Search in Google Scholar Back to article
Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R.: A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 38, 727–733 (2020)
Search in Google Scholar Back to article
Zhu W., Lei R., Le Duff, Y., Li J., Guo F., Wainberg M.A., Liang C.: The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA. Retrovirology, 12, 1–7 (2015)
Search in Google Scholar Back to article
Zhuang Q., Liu, S., Zhang X., Jiang W., Wang K., Wang S., Peng C., Hou G., Li J., Yu X.: Surveillance and taxonomic analysis of the coronavirus dominant in pigeons in China. Transbound. Emerg. Dis. 67, 1981–1990 (2020)
Search in Google Scholar Back to article

CRISPR/Cas System: An Effective Tool Against Pathogenic Diseases

Abstract

Paradigm

My account